Monthly Archives: April 2014

Dr. Birx sworn in as PEPFAR leader

By on .

Two days after her confirmation as U.S. Global AIDS Coordinator and Ambassador at large, Dr. Deborah Birx was sworn in today to her new office, the U.S. Department of State has announced. The announcement ends five months of waiting for the office to be filled that came during a pivotal point in the U.S. response […]

HIV/AIDS Community applauds Birx’s confirmation

By on .

Advocates began lauding the long-awaited confirmation of Dr. Deborah Birx as the new Global AIDS Ambassador yesterday as soon as the Senate finished unanimously voting for the former head of the CDC’s Global AIDS Program to take over former Ambassador Eric Goosby’s position as the head of PEPFAR. “Her focus, determination and dedication to research […]

Uganda, Nigerian laws impact landscape, while responses remain work in progress

By on .

Nearly four months after Nigerian President Goodluck Jonathan signed his country’s new anti-gay law into effect, and more than two months after Ugandan President Yoweri Museveni followed suit with his signature on a similarly inspired repressive law in his country, the impact of both laws have played out volubly and violently across their landscapes, while […]

Medicines Patent Pool, drugmaker agreement set to expand access to new antiretroviral

By on .

Dolutegravir agreement continue collaboration between British company and Unitaid-launched treatment access organization With a high barrier to drug-resistance, low production costs, low dosing and a potential for pediatric use, the new HIV drug dolutegravir, approved by the U.S. Food and Drug Administration in August, and for use among adults and adolescents by the European Medicines […]

TAG scrutinizes research, policy and prices, Paul Ryan eyes foreign aid, the Global Commission on Drug Policy highlights Hepatitis, and more . . . We’re reading pieces that deserve a second look

By on .

TAGline– Treatment Action Group takes a skeptical look at research and policy in its April Fools Day-released TAGline, highlighting issues, requiring “some degree of advocacy to remedy and ensure that the jokes don’t remain on us.” Among them, publicly funded research that leads to breakthroughs at private pharmaceutical companies that leads to high priced products, […]